Prescribed tests
You offer the interpretation to patients whose test was prescribed by their doctor, when results are delivered: on your portal, in the results e-mail or through our platforms.
For clinical laboratories, clinics, insurers and pharmacies: AI interpretation of lab results, white-label, via API or as a co-branded pathway. Shared revenue on every report sold, with no licence, no set-up fee and no minimum.
Shared revenue on every report sold. The model is built with each partner, according to its organisation and country.
You offer the interpretation to patients whose test was prescribed by their doctor, when results are delivered: on your portal, in the results e-mail or through our platforms.
For prevention and on-demand panels, the interpretation becomes a premium offer, at a price you adjust. Celya, in development, will add a distribution channel for these panels.
When results are delivered, the patient wants to understand: you give them the answer, under your brand.
A patient who has understood their results prepares their consultation better; the personal health record supports long-term follow-up.
A tangible prevention service for your members: understand their tests, track their markers, talk to their doctor.
Pharmacy advice backed by a clear reading of results; for distributors, linguistic and regulatory adaptation by country.
Report and patient portal in your colours, hosted by us. No development on your side; live in a few weeks.
Send results from your LIS (HL7, FHIR or other formats) and receive the interpretation, ready to display in your portal.
Your patients reach one of our platforms through a pathway dedicated to your organisation, mentioned in the results-availability e-mail.
Every marker in the report is analysed, then cross-referenced with the others and with the patient's profile.
Three years of physicians' feedback, a framing layer validated by a committee of 13 physicians.
Each version is adapted to its market: units, prescribing habits, local medical sources.
Health data hosted on HDS-certified servers in France, pseudonymised before any AI call.
A complete report generated on a lab result, as a PDF, with an excerpt of its audio summary. Sent on request, then shown in a demo on your own lab results.
Get the sample100+ countries, 40+ languages; 98 % of patients find the report clear, 91 % are ready to recommend it (survey of 30 October 2026, 249 responses).
See the solutionsANSM non-medical-device qualification: the opinion is shared on request, in French and English. HDS hosting, SecNumCloud option, GDPR and EU AI Act documentation.
Request the ANSM opinion13 physicians across specialties review and frame the solution. In all, 8 physicians are shareholders, including one co-founder.
See the teamNo. It helps the patient understand and prepare their consultation; diagnosis remains with the healthcare professional. The co-branded pathway always reminds patients that calling the laboratory remains free.
White label and the co-branded pathway require no development on your side. API integration depends on your LIS; our technical team supports you through to production.
On HDS-certified servers in France (Google Cloud). A SecNumCloud option with OVHcloud or Outscale is available on request.
Blood, urine and stool tests, as PDF or photo, from any laboratory, or directly via API from your LIS (HL7, FHIR or other formats).
We generate a report on a real lab result, in your language, then work out with you the integration and business model suited to your organisation.